4th Quarter - Report

WINNING STRATEGIES WASHINGTON for NOVARTIS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1956 Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1505 Affordable Biologics for Consumers Act

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
MICHAEL A MEROLA —
DONNA MULLINS —
ROBERT ZUCKER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1956 (110th), S. 1505 (110th)

Copyright/Patent/Trademark CPT

H.R. 1908; S. 1145-Patent Reform Act of 2007

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
MICHAEL A MEROLA —
DONNA MULLINS —
ROBERT ZUCKER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.